SUMMARY Renal insufficiency is common in adults with homozygous sickle cell disease, and the contribution of glomerular failure to the hyperuricaemia which is often a feature of the disease has therefore been investigated. In a study of 64 
Hyperuricaemia, which is common in homozygous sickle cell disease, has been ascribed to diminished urate excretion as a consequence of altered renal tubular function.' The possible contribution of altered glomerular function has not been explored, even though diminishing filtration rate is an important feature in older patients. 2 We have therefore investigated the influence of age, creatinine clearance, and tubular damage, as shown by tubular proteinuria, on serum urate concentration and urinary urate excretion. In a previous study3 hyperuricaemia appeared unrelated to bone marrow activity as judged by haemoglobin concentration, reticulocyte count, and serum bilirubin concentration, and these observations have now been extended by measurements of red cell mass and red cell survival.
Patients and methods
Sixty four patients with homozygous sickle cell disease attending the Sickle Cell Clinic at the University Hospital of the West Indies, Kingston, Jamaica, were admitted to a metabolic ward when free of acute complications of their disease. All patients had given informed consent to inclusion in the study. tion of urate (r = -0-60, p < 0-001) were negatively correlated with creatinine clearance. Total urinary urate excretion was positively correlated with creatinine clearance (r = 0-61, p < 0-001). In 10 of the 18 patients who excreted more than 300 mg urinary protein per day, the ratio of urinary albumin concentration to urinary 182-microglobulin concentration was less than 0-3, indicating tubular proteinuria,67 whereas the remainder had ratios which indicated mixed or glomerular proteinuria. Three of the patients with tubular proteinuria had appreciable glomerular failure (creatinine clearance less than 24 ml/min/1.73m2) and were therefore Values given as mean + standard deviation.
In the 19 patients in whom red cell mass and red cell survival was measured, serum urate concentration ranged from 0-18 to 0O48 mmoIIl (mean 0-27 mmolI1). Red cell mass ranged from 13-7 to 201 ml/kg (mean 17.2 ml/kg) and red cell survival (half life) ranged from 4-5 to 21-2 days (mean 10-9 days). There were no significant correlations between serum urate concentration and red cell mass, red cell survival, ratio of red cell mass to red cell survival, haemoglobin concentration, or reticulocyte count, but serum urate was negatively correlated with urate clearance (r = -0-63, p < 0.01).
Discussion
The main factors which influence serum urate concentration are the metabolic production of urate and the way in which it is excreted by the kidneys. Earlier studies' 3have shown that renal urate clearance is a major determinant of serum urate in homozygous sickle cell disease, and our present study confirms this. On the other hand, serum urate concentration has no relation to urate production judged by daily urinary urate excretion, nor to haemoglobin or reticulocyte count, suggesting that hyperuricaemia in sickle cell disease is not closely related to increased bone marrow activity. This conMorgan, Ceulaer, Serjeant clusion receives further support from the measurements of red cell mass and survival, which showed no correlation between red cell turnover and serum urate concentration. Nevertheless, we cannot altogether exclude an effect of increased purine turnover since we have only studied a selected group of young female patients, most of whom were not hyperuricaemic.
Our finding that serum urate concentration was correlated with creatinine clearance suggests that glomerular function has an important effect on urate excretion. We have therefore compared our results with those of Steele and Rieselbach,8 9 who studied serum urate concentration and glomerular function in normal subjects and in patients with renal insufficiency. The relation between serum urate and urate clearance in sickle cell patients is similar to that found in normal subjects (Fig. 1) , but the regression line of serum urate on creatinine clearance (Fig. 2) is displaced to the right of that for non-sickle cell disease patients. A comparison of this sort needs to be interpreted with caution since the difference observed could arise if our method for urate estimation gave higher values than that of Steele and Rieselbach,89 or if our measurements of creatinine clearance overestimated inulin clearance. A systematic difference of urate concentrations is unlikely, however, because urate excretion per millilitre of glomerular filtrate (Fig. 3 ) and fractional excretion of urate both appeared lower in patients with sickle cell disease than in normal subjects. These indices are also of interest because they show that urate excretion per nephron increases with falling glomerular filtration rate as it does in normal subjects, a phenomenon usually attributed to enhanced tubular urate secretion.9 Our relatively high values of creatinine clearance in some patients with sickle cell disease are consistent with other reports'°" indicating that supranormal glomerular filtration rates, measured by either inulin or creatinine clearance, are common. It therefore appears that urate excretion in patients with sickle cell disease is inappropriately low in relation to glomerular filtration rate even though the ability to increase excretion with falling creatinine clearance is preserved.
A possible explanation for our findings stems from the observations that glomeruli in sickle cell disease are particularly large'2 and that glomerular filtra- 
